Highland Capital Management (Tennessee)’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-163,905
Closed -$3.81M 335
2016
Q2
$3.81M Sell
163,905
-2,650
-2% -$58.2K 0.33% 93
2016
Q1
$3.68M Sell
166,555
-5,754
-3% -$129K 0.32% 98
2015
Q4
$3.56M Sell
172,309
-1,732
-1% -$35.4K 0.29% 112
2015
Q3
$3.7M Buy
174,041
+159,788
+1,121% +$3.24M 0.31% 103
2015
Q2
$270K Buy
+14,253
New +$276K 0.02% 303

Other funds holding BTAL

Highland Capital Management (Tennessee)'s BTAL Position: Q3 2016 in Review

Highland Capital Management (Tennessee) sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2016, closing a stake of 163,905 shares — an estimated $3.81M sold.

Highland Capital Management (Tennessee) first reported a position in BTAL in Q2 2015 and held it in 5 quarters. The position peaked at $3.81M in Q2 2016. 10 funds tracked by Wall St. Rank hold BTAL as of Q3 2016.

  • Highland Capital Management (Tennessee) reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2016 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 163,905 AGF US Market Neutral Anti-Beta Fund shares in Q3 2016, an estimated $3.81M.
  • Highland Capital Management (Tennessee) first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2015 and held it in 5 quarters.
  • Highland Capital Management (Tennessee)'s AGF US Market Neutral Anti-Beta Fund position peaked at $3.81M in Q2 2016.
  • 10 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2016.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q3 2016, filed 13 Oct 2016.